337 related articles for article (PubMed ID: 29362226)
1. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
4. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
5. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
6. Vascular changes in the developing rat retina in response to hypoxia.
Rathnasamy G; Sivakumar V; Foulds WS; Ling EA; Kaur C
Exp Eye Res; 2015 Jan; 130():73-86. PubMed ID: 25433125
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
8. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
10. Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood-retinal barrier breakdown.
Kim J; Kim CS; Lee YM; Sohn E; Jo K; Kim JS
Int J Food Sci Nutr; 2015 Mar; 66(2):236-42. PubMed ID: 25582181
[TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
Shin JY; Sohn J; Park KH
J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
[TBL] [Abstract][Full Text] [Related]
12. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
13. Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature.
Jiang Y; Liu L; Steinle JJ
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):185-189. PubMed ID: 28114578
[TBL] [Abstract][Full Text] [Related]
14. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.
Murakami T; Frey T; Lin C; Antonetti DA
Diabetes; 2012 Jun; 61(6):1573-83. PubMed ID: 22438576
[TBL] [Abstract][Full Text] [Related]
17. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
18. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
19. Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.
Yun JH; Park SW; Kim KJ; Bae JS; Lee EH; Paek SH; Kim SU; Ye S; Kim JH; Cho CH
J Cell Physiol; 2017 May; 232(5):1123-1134. PubMed ID: 27580405
[TBL] [Abstract][Full Text] [Related]
20. Microglia increase tight-junction permeability in coordination with Müller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier.
Inada M; Xu H; Takeuchi M; Ito M; Chen M
Exp Eye Res; 2021 Apr; 205():108490. PubMed ID: 33607076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]